BIOCRYST PHARMACEUTICALS INC's ticker is BCRX and the CUSIP is 09058V103. A total of 241 filers reported holding BIOCRYST PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 0.25 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $1,089,838 | +104.3% | 130,676 | +181.2% | 0.04% | +40.0% |
| Q4 2022 | $533,567 | -22.8% | 46,478 | -15.3% | 0.02% | +13.6% |
| Q3 2022 | $691,000 | +9.0% | 54,871 | -6.4% | 0.02% | +22.2% |
| Q2 2022 | $634,000 | -31.2% | 58,645 | +4.7% | 0.02% | 0.0% |
| Q1 2022 | $921,000 | +22.8% | 56,014 | +3.0% | 0.02% | +20.0% |
| Q4 2021 | $750,000 | -20.1% | 54,383 | -16.7% | 0.02% | -16.7% |
| Q3 2021 | $939,000 | +15.6% | 65,312 | +24.6% | 0.02% | +38.5% |
| Q2 2021 | $812,000 | +49.8% | 52,412 | -3.4% | 0.01% | +30.0% |
| Q1 2021 | $542,000 | -15.8% | 54,272 | -36.8% | 0.01% | -28.6% |
| Q4 2020 | $644,000 | +69.9% | 85,880 | -13.2% | 0.01% | +16.7% |
| Q3 2020 | $379,000 | +56.6% | 98,949 | +103.3% | 0.01% | +33.3% |
| Q2 2020 | $242,000 | – | 48,675 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Burrage Capital Management LLC | 1,105,673 | $8,237,000 | 6.28% |
| Sarissa Capital Management LP | 8,175,000 | $60,903,000 | 6.22% |
| ORACLE INVESTMENT MANAGEMENT INC | 2,980,870 | $22,207,000 | 2.78% |
| DG Capital Management, LLC | 1,075,732 | $8,014,000 | 1.70% |
| Ghost Tree Capital, LLC | 900,000 | $6,705,000 | 1.49% |
| Parkman Healthcare Partners LLC | 538,370 | $4,011,000 | 1.03% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 5,835,810 | $43,477,000 | 0.86% |
| Formidable Asset Management, LLC | 470,419 | $3,470,000 | 0.80% |
| KNOTT DAVID M | 219,461 | $1,635,000 | 0.74% |
| Altium Capital Management LP | 250,000 | $1,863,000 | 0.70% |